在帕金森病中观察和模仿对象导向的手动
Judith Bek1,2,3, Emma Gowen4, Stefan Vogt5
1School of Psychology, University College Dublin, Dublin, Ireland. judith.bek@ucd.ie.
Scientific reports
|November 1, 2023
概括
患有帕金森病 (PD) 的人可以模仿对象指向的手动. 然而,它们预测运动可预测性的能力可能会降低,这表明干预应专注于模仿能力.
科学领域:
- 神经科学是一个神经科学.
- 发动机控制器的控制器
- 人类运动科学科学 人类运动科学
背景情况:
- 行动观察和模仿显示出在帕金森病 (PD) 中促进运动的潜力.
- 之前的研究表明,在PD和健康成年人中,不过渡性作用具有类似的模仿性.
- 在PD中使用动力学测量模仿对象定向的手动作仍未得到充分研究.
研究的目的:
- 检查PD患者观察和模仿对象指向的手动.
- 为了比较PD参与者与健康对照者之间模仿的动态测量.
- 在观察任务期间调查运动预测的潜在差异.
主要方法:
- 18名患有PD的参与者和21名年龄相匹配的健康对照者观察并模仿对象导向的手动.
- 在水平位置之间达到和转移一个物体的动力学分析.
- 用眼睛追踪来评估运动观察期间的目光模式.
主要成果:
- 两组人都调节了手指的动作,在升高的轨迹中呈现出更高的垂直幅度,而不是直接的轨迹.
- 对到达段的模拟显示了比转移段更低的垂直幅度和更高的速度.
- 健康对照组在可预测的运动中表现出较小的形尺寸,PD组中没有观察到这种模式.
结论:
- 患有轻度至中度PD的个体可以模仿对象定向手动运动的动力学.
- 关于观察到的运动的预测能力可能会在患有PD的人群中减弱.
- 利用模仿动力学参数的干预措施可能对PD患者有益.
更多相关视频
10:32Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease
Published on: June 17, 2013
55.2K
07:26Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
Published on: September 26, 2019
7.9K
相关概念视频
Parkinson's Disease: Treatment
281
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
281
Parkinson's Disease: Overview
564
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
564
